Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)

Motoi, Fuyuhiko; Kosuge, Tomoo; Ueno, Hideki; Yamaue, Hiroki; Satoi, Sohei; Sho, Masayuki; Honda, Goro; Matsumoto, Ippei; Wada, Keita; Furuse, Junji; Matsuyama, Yutaka; Unno, Michiaki; Group of Preoperative Therapy for Pancreatic Cancer (Prep) and Japanese Study Group of Adjuvant Therapy for Pancreatic cancer (JSAP), Study

doi:10.1093/jjco/hyy190

Public

Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)

Published in Japanese Journal of Clinical Oncology • Dec 5, 2018

Authors:

Fuyuhiko Motoi

Tomoo Kosuge

Hideki Ueno

Abstract

A randomized, controlled trial has begun to compare neoadjuvant chemotherapy using gemcitabine and S-1 with upfront surgery for patients planned resection of pancreatic cancer. Patients were enrolled after the diagnosis of resectable or borderline resectable by portal vein involvement pancreatic can...

Subject

Medicine

Gemcitabine

Clinical endpoint

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!